- Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
-
Cheon YK
- KMID: 1501766
- Korean J Intern Med.
- 2013 Mar;28(2):141-148.
- doi: 10.3904/kjim.2013.28.2.141
Acute pancreatitis remains the most frequent complication of endoscopic retrograde cholangiopancreatography (ERCP), with reported incidence rates that have changed little over several decades. Patient- and procedure-related risk factors for post-ERCP... -
- CITED
-
- Close
- SHARE
-
- Close
- Could Nafamostat or Gabexate Prevent the Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
-
Kwon YH, Kim JY, Lee SJ, Jang SY, Park HW, Yang HM, Jung MK, Jeon SW, Cho CM, Tak WY, Kweon YO, Kim SK
- KMID: 1245208
- Korean J Gastroenterol.
- 2012 Mar;59(3):232-238.
- doi: 10.4166/kjg.2012.59.3.232
BACKGROUND/AIMS: ERCP is the most common procedure for the diagnosis and treatment of bile duct and pancreatic disease, but Post-ERCP pancreatitis makes poor outcome in some cases. The protease inhibitors,... -
- CITED
-
- Close
- SHARE
-
- Close
